US5560369A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Cardiac arrhythmia detection system for an implantable stimulation device and method
Assignee: Pacesetter Inc
•
Filing: 1994-09-22
•
Granted: 1996-10-01
•
Expires: 2014-09-22
Abstract
Abstract A cardiac event and arrhythmia detection system and method detects arrhythmic cardiac activity or other information from an electrogram signal of a heart. The system senses the electrogram signal through an electrogram lead, preliminarily processes the signal, and converts it to a plurality of discrete digital signals, each of which represents the magnitude of the electrogram signal at a prescribed sample time. The discrete digital signals are applied to both a cardiac event detector and a morphology detector. The morphology detector detects selected changes in the morphology (shape) of the electrogram signal, wherein such changes automatically control the sensitivity (gain and/or threshold) used to detect cardiac events. The occurrence of a prescribed amount of change in the detected morphology over time indicates the occurrence of a prescribed arrhythmic cardiac condition.
Inventors
- 👤 Kelly H. McClure
- 👤 Gene A. Bornzin
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 19:18
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/18; A61N1/32; A61N1/36; A61N1/362; A61N1/37; A61N1/3702; A61N1/3704; Y; Y10; Y10S; Y10S128/00; Y10S128/901
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
97 words
An implantable cardiac arrhythmia detection system for detecting the presence of rhythmic and arrhythmic cardiac activity in a heart, the system including an implantable lead that transmits an electrogram signal from the heart, the system comprising: means, coupled to the implantable lead, for determining an average magnitude of the electrogram signal; and means for detecting when the average magnitude exceeds a prescribed threshold, wherein a change less than a prescribed amount indicates the presence of rhythmic cardiac activity and a change greater than the prescribed amount indicates the presence of pathological arrhythmic cardiac activity in the heart.
Claim 2
Dependent Claim
97 words
An implantable cardiac arrhythmia detection system for detecting the presence of rhythmic and arrhythmic cardiac activity in a heart, the system including an implantable lead that transmits an electrogram signal from the heart, the system comprising: means, coupled to the implantable lead, for determining an average magnitude of the electrogram signal; and means for detecting when the average magnitude exceeds a prescribed threshold, wherein a change less than a prescribed amount indicates the presence of rhythmic cardiac activity and a change greater than the prescribed amount indicates the presence of pathological arrhythmic cardiac activity in the heart.
Claim 3
Dependent Claim
28 words
The implantable system, as set forth in claim 1, wherein the determining means comprises: means for determining an average magnitude for a prescribed portion of the electrogram signal.
Claim 4
Dependent Claim
33 words
The implantable system, as set forth in claim 2, wherein the determining means further comprises: means for rectifying the electrogram signal; and means for determining an average magnitude for the rectified electrogram signal.
Claim 5
Dependent Claim
83 words
The implantable system, as set forth in claim 2, wherein the determining means further comprises: converting means for sampling and converting the electrogram signal from the implantable lead to a plurality of unsigned digitized samples; counting means for counting each of the plurality of samples and providing as an output a number of samples; and processing means for accumulating the magnitude of each of the unsigned digitized samples of the electrogram signal, and for dividing the accumulated magnitude by the number of samples.
Claim 6
Dependent Claim
117 words
The implantable system, as set forth in claim 2, wherein the determining means further comprises: timing means for determining the prescribed portion of the electrogram signal, the prescribed portion corresponding to a quiescent portion of the electrogram; converting means for sampling and converting the electrogram signal from the implantable lead to a plurality of unsigned digitized samples during the prescribed portion of the electrogram signal; counting means for counting each of the plurality of samples and providing as an output a number of samples; and processing means for summing the magnitude of each of the unsigned digitized samples of the electrogram signal during the prescribed portion, and for dividing the accumulated magnitude by the number of samples.
Claim 7
Dependent Claim
35 words
The implantable system, as set forth in claim 2, further comprising means for detecting at least one cardiac cycle, wherein the prescribed portion of the electrogram signal corresponds to the at least one cardiac cycle.
Claim 8
Dependent Claim
36 words
The implantable system, as set forth in claim 2, further comprising means for detecting a quiescent portion of the electrogram, wherein the prescribed portion of the electrogram signal corresponds to the quiescent portion of the electrogram.
Claim 9
Dependent Claim
78 words
The implantable system, as set forth in claim 7, wherein the means for detecting a quiescent portion of the electrogram comprises: event detecting means for detecting the occurrence of an R-wave in the electrogram signal; delay means for initiating a delay period following the detection of an R-wave; and timing means for determining a prescribed time interval following the delay period, the prescribed time interval corresponding to a time interval in which R-waves are not expected to occur.
Claim 10
Dependent Claim
76 words
The implantable system of claim 2, wherein the means for detecting when the baseline signal exceeds a prescribed threshold comprises: event detecting means for detecting the occurrence of an R-wave in the electrogram signal; peak detecting means for detecting a peak value of the R-wave; and means for determining the quotient of the peak value divided by the average baseline value and producing as an output an arrhythmia flag whenever the quotient exceeds a prescribed amount.
Claim 11
Dependent Claim
34 words
The implantable system, as set forth in claim 2, further comprising: means for defining the prescribed portion of the electrogram signal as a portion of the electrogram signal which is expected to be quiescent.
Claim 12
Dependent Claim
49 words
The implantable system, as set forth in claim 2, further comprising: means for defining the prescribed portion of the electrogram signal as a complete cardiac cycle containing the electrogram, wherein during normal sinus rhythm, the average magnitude over the entire cardiac cycle approximates the quiescent portion of the electrogram.
Claim 13
Independent Claim
72 words
A method for detecting the presence of rhythmic cardiac activity and arrhythmic cardiac activity, comprising the steps of: (a) sensing an electrogram signal; (b) determining an average magnitude of the electrogram signal; and (c) detecting a change in the average magnitude by a prescribed amount, a change less than the prescribed amount indicating the presence of rhythmic activity and a change greater than the prescribed amount indicating the presence of arrhythmic activity.
Claim 14
Independent Claim
72 words
A method for detecting the presence of rhythmic cardiac activity and arrhythmic cardiac activity, comprising the steps of: (a) sensing an electrogram signal; (b) determining an average magnitude of the electrogram signal; and (c) detecting a change in the average magnitude by a prescribed amount, a change less than the prescribed amount indicating the presence of rhythmic activity and a change greater than the prescribed amount indicating the presence of arrhythmic activity.
References Cited (Backward Citations)
US4000461A
Cited
US4170227A
Cited
US4250888A
Cited
US4958632A
Cited
US4422459A
Cited
US4503857A
Cited
US4596255A
Cited
US4554920A
Cited
US4812976A
Cited
US4726380A
Cited
US4875483A
Cited
US4583553A
Cited
US4552154A
Cited
US4589420A
Cited
US5065766A
Cited
US4817605A
Cited
US4791936A
Cited
US4729376A
Cited
US4674509A
Cited
US4708142A
Cited
US4674508A
Cited
US4708144A
Cited
US4960123A
Cited
US4940052A
Cited
US5086772A
Cited
US5301677A
Cited
US5273049A
Cited
US5330507A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-10-01 | 2000-04-01 | 2000-10-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-10-01 | 2004-04-01 | 2004-10-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-10-01 | 2008-04-01 | 2008-10-01 | $7700.00 | Window Closed / Lapsed |